Goldenwell Biotech, Inc. (GWLL) presents a deeply negative liquidation recovery posture as of September 30, 2025. Total assets of $220,410 consist entirely of cash ($45,622) and inventory ($174,788); no PP&E, no intangibles, no receivables. Applying standard liquidation haircuts yields approximately $45,622 (cash at 100%) plus roughly $104,873 (inventory at 60%) for total adjusted asset recovery of approximately $150,500. Total liabilities at face value are $315,233, composed of $39,360 in current liabilities (principally $37,500 unearned service revenue and $1,860 unearned sales revenue), $95,588 in a related-party noncurrent loan from the CEO, and $189,250 in other noncurrent liabilities net of a $8,965 unamortized discount (gross face $189,250 used at face for liquidation purposes). Net liquidation recovery to equity is approximately negative $164,700, consistent with the reported GAAP stockholders deficit of $(94,823) which itself understates the liquidation shortfall due to inventory haircut. The MFFAIS-reported CLV/LLV of $6,262 reflects only the current liquid asset slice net of current liabilities, which is directionally consistent but understates the full liability stack. Since the prior filing (June 30, 2025), total liabilities decreased from $350,633 to $315,233, primarily because $37,500 of unearned service revenue recognized as revenue in Q3 reduced the deferred service revenue balance from $62,500 to $37,500, though the balance sheet now shows $37,500 DeferredRevenueCurrent versus $62,500 in the prior period. Cash declined from $76,507 to $45,622 as operating cash burn continued with no new financing. The inventory balance is unchanged at $174,788 since inception of the related-party purchase in 2021, with zero cost of goods sold recorded in the current period, raising staleness concerns for liquidation purposes — the product (Goldenwell DNA Repair) has not meaningfully turned over, and actual distressed realizable value may be well below the 60% standard haircut. The $189,250 gross long-term liability is tagged as OtherLiabilitiesNoncurrent; the filing does not separately disclose the nature or terms of this obligation beyond the CEO-sourced related-party loans totaling $95,588; the residual $93,662 ($189,250 minus $95,588) is not separately explained in XBRL or in the notes. The company has accumulated a deficit of $1,407,226 since inception, generates de minimis revenue ($62,500 service revenue YTD 2025, zero product sales), and carries a full valuation allowance on $295,518 of deferred tax assets. Going concern qualification is in place.
▼ Community Notes